BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8833457)

  • 1. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies.
    Donovan JC; Dekoven JG
    Dermatitis; 2006 Sep; 17(3):147-51. PubMed ID: 16956468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
    Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-reactivity patterns to budesonide.
    Ferguson AD; Emerson RM; English JS
    Contact Dermatitis; 2002 Dec; 47(6):337-40. PubMed ID: 12581279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new corticosteroids: are they effective and safe?
    Degreef H; Dooms-Goossens A
    Dermatol Clin; 1993 Jan; 11(1):155-60. PubMed ID: 8435911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-sensitization to mometasone furoate in patients with corticosteroid contact allergy.
    Räsänen L; Tuomi ML
    Contact Dermatitis; 1992 Nov; 27(5):323-5. PubMed ID: 1493689
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.